Peripheral blood leukocyte expression level of IncRNA steroid receptor RNA activator (SRA) and its association with polycystic ovary syndrome: a case control study
Peripheral blood leukocyte expression level of IncRNA steroid receptor RNA activator (SRA) and its association with polycystic ovary syndrome: a case control study
复制标题
外周血白细胞lncRNA类固醇受体RNA激活剂(SRA)表达水平及其与多囊卵巢综合征的关联:病例对照研究
DOI:
10.3109/09513590.2014.999763
复制
发表时间:
2015-05-01
影响因子:
2
通讯作者:
Qu, Qinglan
中科院分区:
文献类型:
--
作者:
Liu, Zhenteng;Hao, Cuifang;Qu, Qinglan
Polycystic ovary syndrome (PCOS) has been recognized as a common reproductive and endocrine disorder. Long noncoding RNA (IncRNA) steroid receptor RNA activator (SRA) affects multiple biological processes. However, it is not known whether IncRNA SRA is associated with PCOS. In the study, we measured the expression level of IncRNA SRA in PCOS patients, and analyzed the association between IncRNA SRA and multiple key endocrine parameters of PCOS. LncRNA SRA expression was significantly higher in the women with PCOS than that in the controls. There was a significant positive correlation between IncRNA SRA expression and BMI in PCOS group. Furthermore, obesity positively associates with the high expression of IncRNA SRA in PCOS women but without the association in control women. In conclusion, we found that the IncRNA SRA expression is potentially associated with PCOS and it has positive correlation with obesity in PCOS, thereby suggesting that elevated IncRNA SRA might be an important mediator in adiposity-related processes in PCOS for susceptible individuals.